Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) released a profit for full year that Dropped, from the same period last year
The company's earnings came in at RMB2.131 billion, or RMB2.77 per share. This compares with RMB2.229 billion, or RMB2.89 per share, last year.
The company's revenue for the period fell 32.7% to RMB4.917 billion from RMB7.308 billion last year.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited earnings at a glance (GAAP) :
-Earnings: RMB2.131 Bln. vs. RMB2.229 Bln. last year.-EPS: RMB2.77 vs. RMB2.89 last year.-Revenue: RMB4.917 Bln vs. RMB7.308 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.